SCHEMBL9867503

SCHEMBL9867503

COc1ccc(-c2nsc(S(N)(=O)=O)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.52
MAPT P10636 5/20 0.46
CA2 P00918 5/20 0.46
CA1 P00915 4/20 0.46
CA9 Q16790 4/20 0.46
CA12 O43570 3/20 0.46
TP53 P04637 3/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CA4 P22748 1/20 0.43
CA5A P35218 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
PTGS2 P35354 3/20 0.43
PTGS1 P23219 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CLK4 Q9HAZ1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866517 0.84 CA2 (0.51) ADORA3MAPTCA2CA1CA9
SCHEMBL9867042 0.82 CYP19A1 (0.54) ADORA3MAPTCA2CA1CA9
SCHEMBL9866053 0.82 CA2 (0.43) ADORA3MAPTCA2CA1CA9
SCHEMBL9868652 0.82 SOS1 (0.50) ADORA3CA2CA1CA9CA12
SCHEMBL9868097 0.80 CYP19A1 (0.58) ADORA3MAPTCA2CA1CA9
SCHEMBL9865836 0.79 CA2 (0.55) CA2
SCHEMBL9867816 0.79 HSD17B1 (0.46) ADORA3MAPTCA2CA1CA9
SCHEMBL9869169 0.79 CA2 (0.47) MAPTCA2CA1CA9CA12
SCHEMBL9866328 0.79 NPC1 (0.49) ADORA3CA2CA1CA9CA12
SCHEMBL14755809 0.79 MAPT (0.51) ADORA3MAPTTP53ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US claimed
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US disclosed
US-4873239-A GLAUCOMA TREATMENT HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-10-10 US disclosed
EP-0276822-A1 Arylthiadiazolylsulfonamides and derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-08-03 EP disclosed
US-4758578-A Arylthiadiazolylsulfonamides, pharmaceutical compositions and use HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) 1988-07-19 US disclosed